• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物警戒教育干预措施以提高医疗保健专业人员的知识、态度和药物不良反应报告:系统评价和荟萃分析。

Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis.

机构信息

Anatomy Department, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

Clinical Pharmacology Laboratory, UMIEZ, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México (UNAM), Batalla 5 de Mayo s/n Esquina Fuerte de Loreto, Col. Ejército de Oriente, Iztapalapa, Mexico City, C.P. 09230, Mexico.

出版信息

Daru. 2024 Jun;32(1):421-434. doi: 10.1007/s40199-024-00508-z. Epub 2024 Mar 1.

DOI:10.1007/s40199-024-00508-z
PMID:38427161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11087385/
Abstract

OBJECTIVES

Underreporting of adverse drug reactions (ADRs) limits and delays the detection of signs. The aim of this systematic review with meta-analyses was to synthesize the evidence of educational interventions (EIs) efficacy in health professionals to increase ADR reporting, attitudes, and knowledge of pharmacovigilance.

EVIDENCE ACQUISITION

A systematic literature review was carried out to identify randomized clinical trials evaluating the efficacy of EI in pharmacovigilance in health professionals to improve ADR reports, knowledge, and attitude toward pharmacovigilance. ADR reports were pooled by calculating Odds Ratio (OR) with a 95% confidence interval (95%CI), while pharmacovigilance knowledge and attitude were pooled by calculating a mean difference (MD) with 95%CI. In addition, the subanalysis was performed by EI type. Meta-analysis was performed with RevMan 5.4 software. PROSPERO registry CRD42021254270.

RESULTS

Eight hundred seventy-five articles were identified as potentially relevant, and 11 were included in the systematic review. Metanalysis showed that EI increased ADR reporting in comparison with control group (OR = 4.74, [95%CI, 2.46 to 9.12], I = 93%, 5 studies). In subgroup analysis, the workshops (OR = 6.26, [95%CI, 4.03 to 9.73], I = 57%, 3 studies) increased ADR reporting more than telephone-based interventions (OR = 2.59, [95%CI, 0.77 to 8.73], I = 29%, 2 studies) or combined interventions (OR = 5.14, [95%CI, 0.97 to 27.26], I = 93%, 3 studies). No difference was observed in pharmacovigilance knowledge. However, the subanalysis revealed that workshops increase pharmacovigilance knowledge (SMD = 1.85 [95%CI, 1.44 to 2.27], 1 study). Only one study evaluated ADR reporting attitude among participants and showed a positive effect after the intervention.

CONCLUSION

EI improves ADR reports and increases pharmacovigilance knowledge. Workshops are the most effective EI to increase ADR reporting.

摘要

目的

药物不良反应(ADR)报告的漏报限制并延迟了信号的检测。本系统评价和荟萃分析的目的是综合评估教育干预(EI)对提高卫生专业人员 ADR 报告、态度和药物警戒知识的有效性的证据。

证据获取

进行了系统的文献综述,以确定评估 EI 在提高卫生专业人员药物警戒中的 ADR 报告、知识和对药物警戒态度的疗效的随机临床试验。通过计算优势比(OR)和 95%置信区间(95%CI)来汇总 ADR 报告,而通过计算均数差(MD)和 95%CI 来汇总药物警戒知识和态度。此外,还按 EI 类型进行了亚分析。使用 RevMan 5.4 软件进行荟萃分析。PROSPERO 注册 CRD42021254270。

结果

确定了 875 篇可能相关的文章,其中 11 篇被纳入系统评价。荟萃分析表明,与对照组相比,EI 增加了 ADR 报告(OR=4.74,[95%CI,2.46 至 9.12],I=93%,5 项研究)。在亚组分析中,与电话干预(OR=2.59,[95%CI,0.77 至 8.73],I=29%,2 项研究)或联合干预(OR=5.14,[95%CI,0.97 至 27.26],I=93%,3 项研究)相比,工作坊(OR=6.26,[95%CI,4.03 至 9.73],I=57%,3 项研究)增加了 ADR 报告。药物警戒知识没有差异。然而,亚分析显示工作坊增加了药物警戒知识(SMD=1.85,[95%CI,1.44 至 2.27],1 项研究)。只有一项研究评估了参与者的 ADR 报告态度,结果表明干预后有积极影响。

结论

EI 提高了 ADR 报告,并增加了药物警戒知识。工作坊是提高 ADR 报告最有效的 EI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/812a89c1ce0c/40199_2024_508_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/a3a93fbbdd9c/40199_2024_508_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/191cda169d33/40199_2024_508_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/fdd0fa17ddfb/40199_2024_508_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/812a89c1ce0c/40199_2024_508_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/a3a93fbbdd9c/40199_2024_508_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/191cda169d33/40199_2024_508_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/fdd0fa17ddfb/40199_2024_508_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c631/11087385/812a89c1ce0c/40199_2024_508_Fig4_HTML.jpg

相似文献

1
Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis.药物警戒教育干预措施以提高医疗保健专业人员的知识、态度和药物不良反应报告:系统评价和荟萃分析。
Daru. 2024 Jun;32(1):421-434. doi: 10.1007/s40199-024-00508-z. Epub 2024 Mar 1.
2
How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.如何利用信息系统促进药品不良反应报告——一项系统评价与荟萃分析
BMC Med Inform Decis Mak. 2016 Mar 1;16:27. doi: 10.1186/s12911-016-0265-8.
3
Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.患者与医疗保健专业人员自发药物不良反应报告:系统评价。
Drug Saf. 2012 Oct 1;35(10):807-18. doi: 10.1007/BF03261977.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Factors associated with underreporting of adverse drug reactions by patients: a systematic review.与患者不良反应漏报相关的因素:一项系统评价。
Int J Clin Pharm. 2023 Dec;45(6):1349-1358. doi: 10.1007/s11096-023-01592-y. Epub 2023 May 29.
6
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.针对患者及护理人员的干预措施,以提高对镰状细胞病的认识及其相关并发症的识别能力。
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
7
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多患者,在进行子宫内膜破坏术前使用的术前子宫内膜减薄剂。
Cochrane Database Syst Rev. 2013 Nov 15;2013(11):CD010241. doi: 10.1002/14651858.CD010241.pub2.
8
School-based education programmes for the prevention of child sexual abuse.预防儿童性虐待的校本教育计划。
Cochrane Database Syst Rev. 2015 Apr 16;2015(4):CD004380. doi: 10.1002/14651858.CD004380.pub3.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
Psychological and/or educational interventions for the prevention of depression in children and adolescents.预防儿童和青少年抑郁症的心理和/或教育干预措施。
Cochrane Database Syst Rev. 2004(1):CD003380. doi: 10.1002/14651858.CD003380.pub2.

引用本文的文献

1
Pharmacovigilance in Practice: Insights into Knowledge, Attitudes, and Practices of Pharmacists and Pharmacy Technicians in Saudi Arabia.实践中的药物警戒:沙特阿拉伯药剂师和药房技术员的知识、态度及实践洞察
J Res Pharm Pract. 2025 Aug 7;14(2):50-58. doi: 10.4103/jrpp.jrpp_8_25. eCollection 2025 Apr-Jun.
2
The Knowledge, Attitudes, and Experiences of Traditional Korean Medicine Doctors in the Spontaneous Reporting of Adverse Drug Events: A Cross-Sectional Survey.韩国传统医学医生在药品不良反应自发报告方面的知识、态度和经历:一项横断面调查。
Healthcare (Basel). 2025 Jul 7;13(13):1620. doi: 10.3390/healthcare13131620.
3

本文引用的文献

1
National pharmacy associations in the commonwealth: current scenario and future needs to maximise effective contributions of the pharmacy profession towards universal health coverage.英联邦国家的药学协会:当前状况及未来需求,以最大限度地提高药学专业对全民健康覆盖的有效贡献。
J Pharm Policy Pract. 2021 Dec 27;14(1):112. doi: 10.1186/s40545-021-00396-7.
2
Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.护士在药物警戒和药物不良反应报告方面的知识、态度和实践:系统评价。
Biomed Res Int. 2021 Apr 9;2021:6630404. doi: 10.1155/2021/6630404. eCollection 2021.
3
Knowledge, attitudes, and practices of healthcare providers toward ADR reporting regarding thiopurine drugs for the treatment of acute lymphoblastic leukemia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
埃塞俄比亚西北部贡德尔大学综合专科医院医护人员关于用于治疗急性淋巴细胞白血病的硫嘌呤类药物不良反应报告的知识、态度和做法。
Front Pharmacol. 2025 May 19;16:1486415. doi: 10.3389/fphar.2025.1486415. eCollection 2025.
4
Serious adverse drug reactions associated with anti-SARS-CoV-2 vaccines and their reporting trends in the EudraVigilance database.与抗SARS-CoV-2疫苗相关的严重药物不良反应及其在欧洲药品不良反应数据库中的报告趋势
Sci Rep. 2025 May 27;15(1):18582. doi: 10.1038/s41598-025-03428-3.
5
Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring.社区药房干预对接受额外监测药物患者的效果
Integr Pharm Res Pract. 2024 Jul 29;13:115-125. doi: 10.2147/IPRP.S466129. eCollection 2024.
6
Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018-2023.替拉珠单抗的安全性:基于2018 - 2023年美国食品药品监督管理局不良事件报告系统(FAERS)数据库的不成比例性分析
Front Pharmacol. 2024 Jul 10;15:1420478. doi: 10.3389/fphar.2024.1420478. eCollection 2024.
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.
PRISMA 2020 解释和说明:系统评价报告的更新指南和范例。
BMJ. 2021 Mar 29;372:n160. doi: 10.1136/bmj.n160.
4
Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.探索医疗保健专业人员对药物警戒的知识、态度和实践:一项横断面调查。
J Pharm Policy Pract. 2021 Jan 4;14(1):5. doi: 10.1186/s40545-020-00287-3.
5
Increasing adverse drug reaction reporting-How can we do better?提高药物不良反应报告率——我们怎么做才能做得更好?
PLoS One. 2020 Aug 13;15(8):e0235591. doi: 10.1371/journal.pone.0235591. eCollection 2020.
6
Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis.干预措施以提高医疗保健专业人员和患者自发药物不良反应报告:系统评价和荟萃分析。
Expert Opin Drug Saf. 2020 Sep;19(9):1173-1191. doi: 10.1080/14740338.2020.1807003. Epub 2020 Oct 3.
7
Interventions to improve adverse drug reaction reporting: A scoping review.干预措施以改善药物不良反应报告:范围综述。
Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):965-992. doi: 10.1002/pds.4966. Epub 2020 May 19.
8
Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomised controlled trial.评估结构化教育对沙特阿拉伯医院药剂师关于药物不良反应及报告方法知识的影响:一项开放标签随机对照试验。
Drugs Ther Perspect. 2019;35(6):296-300. doi: 10.1007/s40267-019-00621-z. Epub 2019 Mar 27.
9
Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review.过去十年中,干预措施提高医疗保健专业人员不良药物反应报告的有效性:系统评价。
Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):1-8. doi: 10.1002/pds.4906. Epub 2019 Nov 14.
10
Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy.沙特阿拉伯一家大型三级医院的药品不良反应报告:一项激励策略的结果
Ther Adv Drug Saf. 2018 Aug 11;9(10):585-590. doi: 10.1177/2042098618790209. eCollection 2018 Oct.